GGrantIndex
← Search

IMAGE-GUIDED BIDIRECTIONAL EPHB4 AGONIST-BASED THERAPY FOR OVARIAN CANCER

$647,998FY2025Defense Health AgencyDOD

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators

View source on USAspending →
IMAGE-GUIDED BIDIRECTIONAL EPHB4 AGONIST-BASED THERAPY FOR OVARIAN CANCER · GrantIndex